Moynie L, Schnell R, McMahon SA, Sandalova T, Boulkerou WA, Schmidberger JW, Alphey M, Cukier C, Duthie F, Kopec J, Liu H, Jacewicz A, Hunter WN, Naismith JH, Schneider G (2013)
The AEROPATH project targeting Pseudomonas aeruginosa: crystallographic studies for assessment of potential targets in early-stage drug discovery.
Acta Crystallographica Sect F Struct Biol Cryst Commun 69: 25

Geppert T, Hoy B, Wessler S, Schneider G (2011)
Context-based identification of protein-protein interfaces and hot-spot residues
Chemical Biology 18: 344

Ekstrom F, Hornberg A, Artursson E, Hammarstrom LG, Schneider G, Pang YP (2009)
Structure of HI-6*sarin-acetylcholinesterase determined by X-ray crystallography and molecular dynamics simulation: reactivator mechanism and design
PLoS ONE 4: e5957

Schneider G, Neuberger G, Wildpaner M, Tian S, Berezovsky I, Eisenhaber F (2006)
Application of a sensitive collection heuristic for very large protein families: evolutionary relationship between adipose triglyceride lipase (ATGL) and classic mammalian lipases
BMC Bioinformatics 7: 164

Schneider G, Dobrindt U, Bruggemann H, Nagy G, Janke B, Blum-Oehler G, Buchrieser C, Gottschalk G, Emody L, Hacker J (2004)
The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536
Infect Immun 72: 5993

Jansson A, Niemi J, Mantsala P, Schneider G (2003)
Crystal structure of aclacinomycin methylesterase with bound product analogues: implications for anthracycline recognition and mechanism
Journal of Biological Chemistry 278: 39006

Dobrindt U, Blum-Oehler G, Nagy G, Schneider G, Johann A, Gottschalk G, Hacker J (2002)
Genetic structure and distribution of four pathogenicity islands (PAI I(536) to PAI IV(536)) of uropathogenic Escherichia coli strain 536
Infect Immun 70: 6365